RSS

Servier

French pharma company Servier has joined a global effort to prevent non-communicable diseases (NCDs) in lower and middle-income countries (LMICs). Read more

News

A strategic partnership has been formed between biotech company, ImmunoQure, and pharma company, Servier, for the development of an interferon-alpha human autoantibody. Read more

News

The European Commission (EC) has granted marketing authorisation for Servier’s Lonsurf for the treatment of patients with advanced metastatic colorectal cancer (mCRC) Read more

News

XEN-D0103 is a potent and selective oral modulator of the cardiac potassium channel Kv1.5 Read more